Esteban Lopez Sells 250 Shares of Addus HomeCare (NASDAQ:ADUS) Stock

Addus HomeCare Corporation (NASDAQ:ADUS) Director Esteban Lopez sold 250 shares of the stock in a transaction that occurred on Thursday, May 21st. The stock was sold at an average price of $93.00, for a total transaction of $23,250.00. Following the completion of the sale, the director directly owned 3,200 shares of the company’s stock, valued at $297,600. This represents a 7.25% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.

Esteban Lopez also recently made the following trade(s):

• On Tuesday, May 19th, Esteban Lopez sold 250 shares of Addus HomeCare stock. The stock was sold at an average price of $93.00, for a total transaction of $23,250.00.

Addus HomeCare Trading Down 0.7%

Addus HomeCare stock opened at $92.65 on Friday. The firm has a 50 day moving average of $95.72 and a 200 day moving average of $105.47. The firm has a market capitalization of $1.73 billion, a price-to-earnings ratio of 17.13, a P/E/G ratio of 1.27 and a beta of 0.92. Addus HomeCare Corporation has a 12-month low of $89.76 and a 12-month high of $124.43. The company has a current ratio of 1.83, a quick ratio of 1.83 and a debt-to-equity ratio of 0.08.

Addus HomeCare (NASDAQ:ADUS) last released its earnings results on Monday, May 4th. The company reported $1.62 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.52 by $0.10. The company had revenue of $363.50 million during the quarter, compared to analyst estimates of $366.41 million. Addus HomeCare had a net margin of 6.89% and a return on equity of 9.80%. The firm’s quarterly revenue was up 7.7% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.42 EPS. As a group, research analysts predict that Addus HomeCare Corporation will post 6.24 earnings per share for the current year.

Wall Street Analysts Forecast Growth

ADUS has been the subject of a number of research analyst reports. KeyCorp reaffirmed an “overweight” rating on shares of Addus HomeCare in a report on Wednesday, February 25th. Royal Bank Of Canada reaffirmed an “outperform” rating and set a $139.00 price objective on shares of Addus HomeCare in a report on Wednesday, February 25th. Barclays cut their price objective on shares of Addus HomeCare from $102.00 to $92.00 and set an “underweight” rating for the company in a report on Friday, May 15th. Weiss Ratings lowered shares of Addus HomeCare from a “hold (c)” rating to a “hold (c-)” rating in a report on Friday. Finally, Stephens cut their price objective on shares of Addus HomeCare from $140.00 to $135.00 and set an “overweight” rating for the company in a report on Wednesday, February 25th. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $131.22.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the company. Global Retirement Partners LLC boosted its position in shares of Addus HomeCare by 395.7% during the 4th quarter. Global Retirement Partners LLC now owns 233 shares of the company’s stock valued at $25,000 after acquiring an additional 186 shares during the last quarter. Larson Financial Group LLC boosted its position in shares of Addus HomeCare by 133.3% during the 3rd quarter. Larson Financial Group LLC now owns 238 shares of the company’s stock valued at $28,000 after acquiring an additional 136 shares during the last quarter. Acumen Wealth Advisors LLC bought a new position in shares of Addus HomeCare during the 4th quarter valued at approximately $29,000. Arax Advisory Partners boosted its position in shares of Addus HomeCare by 95.8% during the 4th quarter. Arax Advisory Partners now owns 280 shares of the company’s stock valued at $30,000 after acquiring an additional 137 shares during the last quarter. Finally, Private Trust Co. NA boosted its position in shares of Addus HomeCare by 65.5% during the 4th quarter. Private Trust Co. NA now owns 283 shares of the company’s stock valued at $30,000 after acquiring an additional 112 shares during the last quarter. 95.35% of the stock is currently owned by institutional investors.

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.